Find Academic Supervisors

Michael McAlpineView profile

Professor

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +4 more

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

David EricksonView profile

Professor

• Global Health Technology
• Medical Diagnostics
• Microfluidics
• +5 more

David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.

• Public Health
• Health Promotion
• Behavioral Science
• +10 more

Rik Crutzen is a Full Professor at the Faculty of Health, Medicine and Life Sciences, Maastricht University, specializing in health promotion and digital interventions. His research focuses on leveraging technology to improve health behaviors across diverse populations, including adolescents, older adults, and immigrant communities. He leads projects in the CAPHRI research group for Promoting Health & Personalised Care. Research trends include: Digital health innovations (e.g., helplines, apps, algorithms) Chronic disease management (post-COVID-19, dementia risk) Health equity in immigrant populations (cervical cancer, maternal care) Behavioral interventions (physical activity, sleep, STI prevention) Systematic reviews and mixed-methods studies He has supervised 22 academic works and contributed to datasets on activity patterns and sleep-activity correlations. His work spans public health policy, health education, and technology integration.

Karen CheungView profile

Professor

• Biomedical microsystems
• Lab-on-a-chip systems
• Tissue engineering
• +9 more

Karen C. Cheung is a Professor in the Department of Electrical and Computer Engineering at the University of British Columbia, with cross-appointments in the Faculty of Medicine and the School of Biomedical Engineering where she serves as Director of the Graduate Program. She holds her office in KAIS 3064 and can be reached at (604) 827-4114. Dr. Cheung received her BSc and PhD degrees in Bioengineering from the University of California, Berkeley in 1998 and 2002, respectively. From 2002-2005, she was a postdoctoral researcher at the École Polytechnique Fédérale de Lausanne in Switzerland. She joined UBC in 2006 and has established herself as a leading researcher in biomedical microsystems. Her research spans multiple areas of biomedical engineering with particular focus on lab-on-a-chip systems for cell culture and characterization , inkjet printing for tissue engineering , and implantable neural interfaces . Her work integrates microfluidics, biosensors, and tissue engineering to create platforms that better mimic in vivo conditions for drug screening and disease modeling. Current projects include developing organ-on-a-chip models of the human airway for studying aerosol exposure effects, creating microscale tumor models for cancer research, and advancing silicon photonic biosensors for medical diagnostics. Dr. Cheung leads the Bio-Medical Micro Devices Laboratory at UBC, which houses multiple research teams working on cutting-edge biomedical technologies. Her lab has developed microfluidic platforms capable of precisely controlling oxygen levels around tumor spheroids to study cancer treatment responses under realistic physiological conditions. The lab also works on novel fabrication techniques for microelectrode arrays and tissue clearing protocols for 3D imaging of microtissues. As an educator, Dr. Cheung teaches several specialized courses including ELEC 361 (Molecules to Mechanisms), ELEC 464 (Nanotechnology and Nature), EECE 301 (Topics in Nanotechnology and Microsystems), ELEC 473 (Biological Micro-Electro-Mechanical Systems), and ELEC 521 (Biomedical Microdevices). She has supervised numerous graduate students through their MASc, PhD, and postdoctoral work, with many alumni now holding academic positions or working in the biomedical industry. Her research is supported through multiple funding sources and collaborations with industry partners. Dr. Cheung is affiliated with several research centers including the Airway Centre, Bionics Network, Centre for Blood Research, and the Institute for Computing, Information and Cognitive Systems (ICICS) at UBC.

Ashli Owen-SmithView profile

Researcher

• Mental Health
• Behavioral Science
• Trauma
• +6 more

Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .

Kristofer S.J. PisterView profile

Professor

• Micro/Nano Electro Mechanical Systems (MEMS)
• Control Systems
• Robotics
• +6 more

Kristofer Pister is a Professor in the Department of Electrical Engineering and Computer Sciences at the University of California, Berkeley. He co-directs the Berkeley Sensor and Actuator Center (BSAC) and the Ubiquitous Swarm Lab. His career spans groundbreaking innovations in Micro/Nano Electro Mechanical Systems (MEMS), Control Systems, and Low-Power Circuits, with a focus on Smart Dust and synthetic insects. Education: Ph.D. and M.S. in EECS from UC Berkeley (1992, 1989); B.A. in Applied Physics from UC San Diego (1986). His research areas include MEMS , Control Systems , Robotics , and Integrated Circuits , with recent work on self-powered micro-sensors, crystal-free radios, and interplanetary swarm networks. Key awards include the ISA Albert F. Sperry Founder Award (2009) , Alexander Schwarzkopf Prize (2006) , and the NSF CAREER Award (1996) . He has authored numerous influential publications in wireless sensor networks and microrobotics. His lab, Ubiquitous Swarm Lab , explores distributed robotics and swarm intelligence. Pister emphasizes open collaboration in research, ethical conduct in academia, and efficient resource utilization for graduate students.

Waldemar KolanusView profile

Professor

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +4 more

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

Deniz TasdemirView profile

Professor

• Marine Natural Products Chemistry
• Marine Ecology
• Biodiscovery
• +2 more

Prof. Dr. Deniz Tasdemir is a Full Professor (W3) of Marine Natural Products Chemistry at GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel and serves as Director of the GEOMAR-Biotech center and Head of the Marine Natural Product Chemistry Research Unit. Her career spans institutions including the National University of Ireland Galway and UCL School of Pharmacy. PhD in Pharmacy, ETH Zurich (1997) Post-doctoral work, University of Utah (2001) Dr. Helmut Legerlotz Fellowship, University of Zurich (2002-2025) Her research focuses on marine chemical ecology , metabolomics , and bioprospecting for bioactive compounds from sponges, algae, and marine microbiomes. Recent work explores seagrass pathogen reduction, microbiome interactions, and aquafeed applications. Scientific awards include: Waters Award for Natural Products Innovation (2016) Egon Stahl Silver Medal (2005) Pierre Fabre Prize (2004) ETH Zurich Medal (1997) She leads collaborative projects on ocean sustainability and marine drug discovery, with editorial roles in Marine Drugs , Planta Medica , and Phytochemistry Letters .

• Stem Cell Biology
• Genetic Engineering
• Epigenetics
• +5 more

Konstantinos Anastassiadis is a Professor at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University of Technology , leading the Stem Cell Engineering group at the Biotechnology Center (BIOTEC) . His research focuses on unraveling molecular pathways regulating stem cell self-renewal and lineage commitment, with a strong emphasis on genetic engineering tool development and epigenetic mechanisms during cellular reprogramming. The lab utilizes mouse and human embryonic stem cells, neural stem cells, mesenchymal stromal cells, and induced pluripotent stem cells (iPSCs) in their investigations. Core Research Areas: Molecular regulation of stem cell fate Epigenetic mechanisms (e.g., UTX/UTY histone demethylases) Genetic engineering tool development (Flp, Dre, Vika recombinases, CRISPR protocols) Conditional immortalization systems for rare cell expansion Publications highlight his contributions to understanding: Role of histone methyltransferases (MLL1, MLL2, Setd1b) in hematopoiesis and cancer Epigenetic regulation during mouse development and spermatogenesis Genetic tools for protein tagging, transposon-mediated BAC transgenesis Interactions between stem cells and niche microenvironments Transcriptional and mechanical markers during reprogramming Collaborations span immunology , developmental biology , and bioinformatics . The lab actively participates in teaching activities at CMCB and maintains a focus on translational applications of stem cell research.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +7 more

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

Omer BayraktarView profile

Researcher

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +3 more

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

John A. Copland, IIIView profile

Professor

• Cancer Biology
• Molecular Carcinogenesis
• Translational Research
• +3 more

Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models

John E. MosesView profile

Professor

• Click Chemistry
• Cancer Drug Development
• Antibiotic Discovery
• +4 more

John E. Moses is a Professor at Cold Spring Harbor Laboratory (CSHL), where he leads the Moses Laboratory and serves as Faculty Head of the Mass Spectrometry Shared Resource for the Cancer Center. He is also a Cancer Center Member focusing on developing chemical tools for biological discovery, particularly in cancer research. Dr. Moses earned his D.Phil. in Synthetic Organic Chemistry from the University of Oxford in 2004. His academic journey includes positions as Professor of Organic Chemistry at La Trobe University (2017-2020), Level 6 Future Fellow at the Australian Research Council (2017-2021), and Reader & Associate Professor in Organic Chemistry at the University of Nottingham (2007-2017). Moses' research focuses on click chemistry, a powerful discovery method that uses robust chemical reactions to synthesize functional molecules. His lab specializes in developing and exploiting bond-forming click reactions for rapid synthesis of small functional molecules, including cancer drugs and chemical probes. They apply these molecular tools in multidisciplinary projects spanning biology and chemistry. His recent work has led to significant advances in click chemistry methodologies, including Diversity Oriented Clicking (DOC) and Phosphorus Fluoride Exchange (PFEx). These approaches have enabled the discovery of new cancer therapeutics and antibiotics effective against multidrug-resistant bacteria like MRSA. Dr. Moses has received numerous honors including the 2021 Organic Division Horizon Prize: Robert Robinson Award in Synthetic Organic Chemistry, Fellow of the Royal Society of Chemistry (2015), Thieme Chemistry Award (2011), and UK & ROI Lilly Award for Excellence in Organic Chemistry (2011). Through his work at CSHL, Moses mentors students and postdoctoral researchers while collaborating with biologists to develop Chemistry For Biology. His lab's innovative approaches have been supported by multiple grants, including those from the National Cancer Institute. The Moses Laboratory is at the forefront of click chemistry research, developing new methodologies while applying them to solve critical problems in cancer biology and antibiotic resistance.

Lucian SulicaView profile

Professor

• Voice Disorders
• Laryngology
• Vocal Fold Injuries
• +7 more

Dr. Lucian Sulica is the Sean Parker Professor of Laryngology and Director of the Sean Parker Institute for the Voice at Weill Cornell Medical College. He is an attending Otolaryngologist at NewYork-Presbyterian Hospital with a clinical practice exclusively focused on voice disorders. Dr. Sulica served as the 2023 President of the American Laryngological Association and is a Fellow of the American Laryngologic, Rhinologic and Otologic Society (the Triologic Society). His educational background includes: A.B. from Dartmouth College (1989) M.D. from Georgetown University School of Medicine (1993) Residency at Georgetown University Medical Center Fellowship at New York Center for Voice & Swallowing Disorders, St. Luke's-Roosevelt Hospital Center Dr. Sulica's research focuses on evidence-driven principles for treating voice conditions, with particular emphasis on vocal fold injuries from voice use (especially in performers), neurologic voice disorders (including vocal fold paralysis, spasmodic dysphonia, and tremor), and in-office procedures for voice disorders that don't require general anesthesia. His work has addressed critical aspects such as gender differences in vocal fold injury, pathophysiology of laryngeal nerve injury, and diagnostic accuracy in voice disorders. Analysis of Dr. Sulica's recent publications reveals a strong focus on advancing diagnostic techniques through artificial intelligence, improving surgical outcomes for vocal fold lesions, understanding performers' unique voice care needs, and developing evidence-based protocols for vocal fold hemorrhage and other voice disorders. His research increasingly incorporates technology-driven approaches while maintaining a strong clinical focus on patient-centered outcomes. Dr. Sulica has received numerous prestigious awards including: Casselberry Award of the American Laryngological Association (2021) Felix Semon Lectureship in Laryngology, Royal Society of Medicine (2022) American Academy of Otolaryngology – Head & Neck Surgery Honor Award (2008) Consistent recognition as one of "Best Doctors in America" (2005-2024) Designation as one of "America's Top Physicians in Voice Disorders/Laryngology" (since 2006) Inclusion in "New York Magazine Best Doctors" list annually since 2013 As an educator, Dr. Sulica has authored more than 110 journal articles and 40 book chapters, and has edited three books including "Vocal Fold Paralysis," "Classics in Voice and Laryngology," and "Patologia Laringea y Fonocirugia" (in Spanish). He is passionate about teaching and has lectured extensively across the United States, Europe, Latin America, and Australia. His clinical work at the Sean Parker Institute for the Voice represents a comprehensive approach to voice care, incorporating innovative in-office procedures that have helped establish new standards in laryngology.

Raphael FranziniView profile

Associate Professor

• Drug Discovery
• Medicinal Chemistry
• Bioorthogonal Chemistry
• +3 more

Raphael Franzini serves as Associate Professor of Medicinal Chemistry at the University of Utah, actively contributing to the Biological Chemistry PhD Program. His research pioneers innovative chemical approaches for therapeutic development, with dual focus on DNA-encoded library technologies and bioorthogonal drug delivery systems. His educational foundation includes an M.S. from the Swiss Federal Institute of Technology (Lausanne) and a Ph.D. from Stanford University. This training underpins his group's multidisciplinary methodology combining organic synthesis, bioconjugation, computational modeling, and advanced imaging techniques. Dr. Franzini's research program centers on two transformative areas: First, advancing DNA-encoded library screening through computational integration to identify leads for challenging targets like Tankyrase and Sirtuin 6, with recent work addressing false negatives in machine learning prediction. Second, developing novel bioorthogonal release chemistry using isonitrile-tetrazine reactions for spatiotemporally controlled drug activation, validated in zebrafish models. His group emphasizes both technological innovation and therapeutic translation, with chemistry designed to minimize off-target effects in solid tumors. Analysis of his 15 most recent publications reveals escalating integration of computational methods with experimental library screening, alongside refinement of bioorthogonal release kinetics. The work spans chemical biology, medicinal chemistry, and pharmaceutical sciences, with growing emphasis on machine learning for library data interpretation and in vivo validation of drug-release systems. Dr. Franzini maintains an active research laboratory that provides comprehensive training in cutting-edge drug discovery methodologies. His group culture prioritizes both scientific innovation and researcher development, with projects spanning from fundamental reaction kinetics to therapeutic applications. The lab's infrastructure supports organic synthesis, molecular imaging, and computational analysis for advancing precision therapeutics.